152 related articles for article (PubMed ID: 19085836)
21. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
22. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
23. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
24. RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo.
Zhou H; Tang Y; Liang X; Yang X; Yang J; Zhu G; Zheng M; Zhang C
Int J Cancer; 2009 Jul; 125(2):453-62. PubMed ID: 19391133
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract][Full Text] [Related]
26. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
27. Promotion of cell differentiation, and suppression of cell growth and cyclooxygenase-2 expression by differentiation-inducing agents in human oral squamous carcinoma SCC25 cells.
Kuroda J; Urade M; Kishimoto H; Noguchi K; Hashitani S; Sakurai K; Nishimura N; Hashimoto-Tamaoki T
Int J Oncol; 2005 Feb; 26(2):361-7. PubMed ID: 15645120
[TBL] [Abstract][Full Text] [Related]
28. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.
Zhong LP; Yang X; Zhang L; Wei KJ; Pan HY; Zhou XJ; Li J; Chen WT; Zhang ZY
Oncol Rep; 2008 Dec; 20(6):1441-7. PubMed ID: 19020726
[TBL] [Abstract][Full Text] [Related]
30. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Tomita R; Sento S; Kitamura N; Yamamoto T
PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
[TBL] [Abstract][Full Text] [Related]
31. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis.
Nozaki S; Endo Y; Kawashiri S; Nakagawa K; Yamamoto E; Yonemura Y; Sasaki T
Oral Oncol; 1998 Jan; 34(1):58-62. PubMed ID: 9659521
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor.
Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Hashiba Y; Kawashiri S; Tanaka A; Nakagawa K; Matsuoka Y; Kogo M; Yamamoto E
Oral Oncol; 2005 Nov; 41(10):971-7. PubMed ID: 16129656
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
35. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis.
Lo WY; Tsai MH; Tsai Y; Hua CH; Tsai FJ; Huang SY; Tsai CH; Lai CC
Clin Chim Acta; 2007 Feb; 376(1-2):101-7. PubMed ID: 16889763
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
[TBL] [Abstract][Full Text] [Related]
37. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
Ding N; Luo M; Liao XL; Bao QY; Li RY; Wu B
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6202-6210. PubMed ID: 31364120
[TBL] [Abstract][Full Text] [Related]
39. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
J Exp Clin Cancer Res; 2016 Jun; 35(1):92. PubMed ID: 27297407
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma.
Kupferman ME; Patel V; Sriuranpong V; Amornphimoltham P; Jasser SA; Mandal M; Zhou G; Wang J; Coombes K; Multani A; Pathak S; Silvio Gutkind J; Myers JN
Oral Oncol; 2007 May; 43(5):440-54. PubMed ID: 16978912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
